Incidence, Risk Factors, and Clinical Sequelae of Angiographic Peri-Stent Contrast Staining After Sirolimus-Eluting Stent Implantation
Author(s) -
Masao Imai,
Kazushige Kadota,
Tsuyoshi Goto,
Satoki Fujii,
Hiroyuki Yamamoto,
Yasushi Fuku,
Shingo Hosogi,
Akitoshi Hirono,
Hiroyuki Tanaka,
Takeshi Tada,
Takeshi Morimoto,
Hiroki Shiomi,
Ken Kozuma,
Katsumi Inoue,
Nobuaki Suzuki,
Takeshi Kimura,
Kazuaki Mitsudo
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.110.003459
Subject(s) - medicine , sirolimus , stent , peri , incidence (geometry) , drug eluting stent , radiology , surgery , cardiology , restenosis , physics , optics
We have noted abnormal angiographic findings--at the sites of drug-eluting stent implantation, suggesting contrast staining outside the stent struts--that do not fulfill the classic definition of coronary artery aneurysm. We propose a new term, peri-stent contrast staining (PSS), for these abnormal angiographic findings and assess their incidence, risk factors, and clinical sequelae.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom